| Pharmaceutical | Generic formulations including tablets, capsules, injectables, ophthalmic products. | Regulatory certifications, product registrations, and manufacturing capacity upgrades. | Hospitals, nursing homes, dispensing doctors, and international buyers; B2B and B2C. | Ophthalmic and injectable segments with higher regulatory barriers. | 42 | 36 | Sales of medicinal formulations primarily in domestic and international markets. | Direct sales with standard pharmaceutical pricing; growing exports post regulatory approvals. | Demand for generics, new product registrations, market expansion. | |
| Chemical Manufacturing | Chemical intermediates and bulk drug manufacturing for internal use and external clients. | Integrated operations with formulation business and proprietary manufacturing processes. | Pharmaceutical companies and chemical industry clients; mainly B2B. | Specialized chemical intermediates with fewer competitors. | 78 | 64 | Sales of chemical products and intermediates supporting formulation business and third parties. | Contract and spot sales based on raw material demand and production capacity. | Expansion of chemical manufacturing capacity and increased pharmaceutical production needs. | |
